Please login to the form below

Not currently logged in
Email:
Password:

Realm Therapeutics appoints Sandy Zweifach as non-executive director

But Matthew Hammond and Daniel Hegglin retire

Biopharmaceutical company Realm Therapeutics has appointed Sandy Zweifach as a new non-executive director following the retirement of Matthew Hammond and Daniel Hegglin, both of whom served as non-executive directors.

Zweifach joins the biopharma with over 25 years’ experience in the life science industry, with a background in corporate partnering, business development, operations, private and public investing and capital raising.

He is founder, president and chief executive officer of Nuvelution Pharma, a company facilitating the clinical advancement of late stage pharmaceutical and biotechnology assets via a research and development risk-sharing approach that deploys capital and human resources.

Prior to this, Zweifach has served in several leadership roles, including CEO of Ascendancy Healthcare, CEO and president of Pathway Diagnostics and president and CFO of Epoch Biosciences.

Alex Martin, chief executive officer, Realm Therapeutics, said: “I am excited to welcome Sandy to the board.

“His background and experience in both the biopharmaceutical industry and investment banking will be helpful as we progress our pipeline and expand our optionality in 2018 and beyond.”

23rd November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics